Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Menopause. 2012 Aug;19(8):931–941. doi: 10.1097/gme.0b013e31824362ff

FIG. 2.

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

FIG. 2

Kaplan-Meier estimates of cumulative hazards for clinical outcomes by MHT exposure status. MHT, menopausal hormone therapy; DVT, deep venous thrombosis; PE, pulmonary embolism; E, estrogen; P, progestin.